Back to Jobs
Kailera Therapeutics
Legal & HR Just now

Associate Director, Global Regulatory Affairs

Kailera Therapeutics
United StatesUnited States
Full-time
$155,000–$190,000 USD
Senior-Level

Job Description

What You’ll Do:

The Associate Director, Global Regulatory Affairs will be responsible for day-to-day regulatory activities of early/late phase investigational products, leading the writing and submission of IND/CTA/amendments and future marketing application submissions, providing guidance to the team on regulatory filings and responses, and offering critical regulatory intelligence and guidance back to the team. The role involves working on cross-functional teams, partnering with key internal/external team members including Regulatory CMC and Regulatory Operations to ensure the scientific data and submissions meet agency expectations in a compliant manner.

Responsibilities:

  • Serve as the regulatory representative on core teams, developing and planning regulatory submission strategies, coordinating the preparation of submissions to regulatory agencies, and conducting regulatory intelligence activities
  • Oversee the compilation, review, and submission of regulatory applications and submissions to agencies, ensuring accuracy, completeness, and timeliness
  • Monitor the regulatory environment and communicate developments to various stakeholders within the company (clinical, regulatory, senior leadership, etc.)
  • Stay updated on global regulatory guidance and regulations, communicating key updates to senior leadership and project team management to ensure compliance with all reporting requirements, including annual and periodic reports
  • Respond to regulatory questions from various regulatory authorities, working in collaboration with subject matter experts in clinical development, safety, and other business partners
  • Provide strategic regulatory guidance for global development and registration programs (e.g., INDs, CTAs, NDAs, and MAAs)
  • Assess and communicate regulatory requirements to ensure all development activities follow applicable regulations and guidelines
  • Contribute to the implementation of processes and procedures, including developing and authoring internal work instructions and company SOPs

Required Qualifications:

  • Demonstrated knowledge of regulatory requirements in the design and conduct of clinical trials, including preparation of regulatory submissions
  • Established working knowledge of regulatory guidelines and regulations (US and international)
  • Demonstrated deep knowledge of the integrated drug development process
  • Demonstrated ability to find solutions and alternatives through teamwork resulting in positive business outcomes
  • Demonstrated ability to assess and manage risk in a highly regulated environment
  • Strong written, spoken, and presentation communication
  • Strong desire to grow career in the pharmaceutical industry, willingness to learn, and enthusiastically embrace new opportunities
  • Travel expected (10-15%)

Preferred Qualifications:

  • Advanced degree preferred

Education:

  • Bachelor's degree with 10+ years of relevant drug development experience
  • Advanced degree (such as PhD, PharmD, MS, MBA) with at least 5 years of relevant drug development experience

How would you rate this job post?

See what other professionals think about this role.

banner
logo

Kailera Therapeutics

View Company Profile

Kailera Therapeutics is the premier, enterprise-grade clinical-stage biotechnology pioneer, multi-receptor incretin therapy innovator, and metabolic healthcare powerhouse engineered to operate as the definitive, high-velocity developer layer for next-generation obesity and cardiometabolic disease treatments globally. The company completely eliminates the severe systemic friction of modern weight-management therapeutics—where first-generation single-receptor treatments face commercial efficacy ceilings, plateaus in total body weight loss, injection delivery barriers, and challenging gastrointestinal side effects—by deploying an advanced, multi-pronged incretin and small-molecule discovery platform. Moving far beyond traditional, passive disease research models or isolated chemical formulation screening, Kailera natively unifies once-weekly injectable dual-agonist peptides (ribupatide/KAI-9531 targeting GLP-1 and GIP), highly differentiated once-daily oral small-molecule alternatives, and next-generation triple-agonist (triple-G) programs (KAI-4729 targeting GLP-1, GIP, and glucagon receptors) into a unified, high-conviction clinical portfolio. Launched via a record-shattering $625 million initial public offering (IPO) on the Nasdaq Stock Market (NASDAQ: KLRA) that bypassed typical early biotech capital constraints, the firm maintains an expansive financial run-rate to advance its broad global Phase 2b and Phase 3 KaiNETIC clinical development tracks with production-hardened scientific precision. Under the hood, its sophisticated technical practice leverages exclusive ex-China asset licenses from global pharmaceutical giant Jiangsu Hengrui, running automated high-throughput data pipelines, rigorous multi-tenant patient trial monitoring frameworks, and strict FDA and global health authority compliance structures. What sets Kailera Therapeutics apart is its uncompromising dedication to replacing mechanical treatment protocols with absolute therapeutic options and long-term metabolic health momentum; by bridging the gap between performance-intensive big data receptor analytics and convenient, highly tolerable patient-centric treatments, the institution remains the definitive, category-defining cornerstone of modern incremental weight loss and metabolic clinical innovation.

Safety First

  • Never pay for a job application.
  • Do not share sensitive bank info.
  • Verify the client before starting work.
Learn More
Associate Director, Global Regulatory Affairs at Kailera Therapeutics | HireSkys